SEC Form 4 · accession 0001102624-15-000150
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Platt
Officer — CEO and Chairman · Director · 10% Owner
Period of report
Feb 2, 2015
Accepted (ET)
Feb 4, 2015 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2015 | P | 200 | $0.478 | A | 7,545,085 | D | |
| Common Stock | Feb 3, 2015 | P | 200 | $0.41 | A | 7,545,285 | D | |
| Common Stock | Feb 4, 2015 | P | 200 | $0.41 | A | 7,545,485 | D |
Table II — derivative securities
No Table II lines on this filing.